BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 30045991)

  • 21. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
    Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera.
    Xie H; Li L; Ye Z; Li X; Plant EP; Zoueva O; Zhao Y; Jing X; Lin Z; Kawano T; Chiang MJ; Finch CL; Kosikova M; Zhang A; Zhu Y; Wan XF
    Clin Infect Dis; 2017 Jul; 65(2):259-267. PubMed ID: 28369230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.
    Iba Y; Fujii Y; Ohshima N; Sumida T; Kubota-Koketsu R; Ikeda M; Wakiyama M; Shirouzu M; Okada J; Okuno Y; Kurosawa Y; Yokoyama S
    J Virol; 2014 Jul; 88(13):7130-44. PubMed ID: 24719430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin.
    Kuwahara T; Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Takahashi H; Suzuki N; Kawaoka Y; Watanabe S; Odagiri T
    Jpn J Infect Dis; 2018 May; 71(3):234-238. PubMed ID: 29709975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.
    Li Y; Bostick DL; Sullivan CB; Myers JL; Griesemer SB; Stgeorge K; Plotkin JB; Hensley SE
    J Virol; 2013 Sep; 87(17):9904-10. PubMed ID: 23824816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites.
    Eshaghi A; Duvvuri VR; Li A; Patel SN; Bastien N; Li Y; Low DE; Gubbay JB
    Influenza Other Respir Viruses; 2014 Mar; 8(2):250-7. PubMed ID: 24313991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins.
    Blanchfield K; Kamal RP; Tzeng WP; Music N; Wilson JR; Stevens J; Lipatov AS; Katz JM; York IA
    Influenza Other Respir Viruses; 2014 Nov; 8(6):628-35. PubMed ID: 25213778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influenza virus hemagglutinin head evolves faster than the stalk domain.
    Kirkpatrick E; Qiu X; Wilson PC; Bahl J; Krammer F
    Sci Rep; 2018 Jul; 8(1):10432. PubMed ID: 29992986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.
    Parker L; Wharton SA; Martin SR; Cross K; Lin Y; Liu Y; Feizi T; Daniels RS; McCauley JW
    J Gen Virol; 2016 Jun; 97(6):1333-1344. PubMed ID: 26974849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.
    Tewawong N; Suntronwong N; Vichiwattana P; Vongpunsawad S; Theamboonlers A; Poovorawan Y
    Virus Genes; 2016 Oct; 52(5):711-5. PubMed ID: 27146171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies.
    Piepenbrink M; Oladunni F; Nogales A; Khalil AM; Fitzgerald T; Basu M; Fucile C; Topham DJ; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
    Microbiol Spectr; 2023 Aug; 11(4):e0472822. PubMed ID: 37318331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.
    Zost SJ; Wu NC; Hensley SE; Wilson IA
    J Infect Dis; 2019 Apr; 219(Suppl_1):S38-S45. PubMed ID: 30535315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017.
    Zhu H; Lee ACY; Li C; Mak WWN; Chen YY; Chan KH; Zhang AJX; Fung WF; Zhang RQ; Fung YF; Poon RWS; Lam JY; Tam S; Hung IFN; Chen H; Yuen KY; To KKW
    Emerg Microbes Infect; 2018 Mar; 7(1):23. PubMed ID: 29511175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.
    Margine I; Krammer F; Hai R; Heaton NS; Tan GS; Andrews SA; Runstadler JA; Wilson PC; Albrecht RA; García-Sastre A; Palese P
    J Virol; 2013 Oct; 87(19):10435-46. PubMed ID: 23903831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B Cells.
    Ursin RL; Dhakal S; Liu H; Jayaraman S; Park HS; Powell HR; Sherer ML; Littlefield KE; Fink AL; Ma Z; Mueller AL; Chen AP; Seddu K; Woldetsadik YA; Gearhart PJ; Larman HB; Maul RW; Pekosz A; Klein SL
    mBio; 2022 Aug; 13(4):e0183922. PubMed ID: 35856618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic.
    Ushirogawa H; Naito T; Tokunaga H; Tanaka T; Nakano T; Terada K; Ohuchi M; Saito M
    BMC Infect Dis; 2016 Aug; 16():380. PubMed ID: 27503338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting antigenic variants of influenza A/H3N2 viruses.
    Lee MS; Chen JS
    Emerg Infect Dis; 2004 Aug; 10(8):1385-90. PubMed ID: 15496238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus.
    Tesini BL; Kanagaiah P; Wang J; Hahn M; Halliley JL; Chaves FA; Nguyen PQT; Nogales A; DeDiego ML; Anderson CS; Ellebedy AH; Strohmeier S; Krammer F; Yang H; Bandyopadhyay S; Ahmed R; Treanor JJ; Martinez-Sobrido L; Golding H; Khurana S; Zand MS; Topham DJ; Sangster MY
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.